Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

A nearby exoplanet orbiting within the habitable zone of a star just 4.2 light-years from Earth may be home to a vast ocean, boosting its chances of supporting life. Since its discovery, questions about the conditions at the surface of Proxima b have been swirling; the planet’s mass is just about 1.3 times that of Earth’s, and the red dwarf star it circles is similar in age to our sun.

Studies over the last few years, however, have both bolstered hopes of its habitability and shot them down. Now, a new study has once again raised the possibility that Proxima b could support life, suggesting that under the right conditions, the exoplanet could sustain liquid water.

Read more | >

Scientists in the Netherlands have developed a model to forecast the energy yield of a PV system. It is able to take into account factors such as partial shading and multiple module orientations. Tested against a reference cell and pyranometer, the model showed less than 5% error, and the scientists claim their approach is up to three orders of magnitude faster than more common approaches using complex ray tracing.

Read more | >

As investors continue to put money into technology companies making a difference, there is a misconception that a majority of investors belong to younger generations. New research shows the distribution in ESG-motivated investment: 54% are Gen Z and millennials, 42% are baby boomers, and 25% are Gen Xers.

ESG Standards That Younger Generations Care About

From combatting climate change to expanding diversity in the boardroom and instituting more corporate equitable policies, technology companies need to understand what Gen Z and Gen X care about. If any sector of the global economy is sensitive to ESG it should be technology with its appeal to younger audiences. That’s why the recent acceleration of widespread reporting on ESG principles and practices is creating a shift in power, money and jobs from baby boomers to millennials and Gen Z, in which passive investing, COVID, social injustice issues, the Great Resignation and talent shortages are all contributing factors.

Read more | >

Gene therapy pioneer — dr. katherine high, MD — president, therapeutics, askbio.

Dr. Katherine High, MD, is President, Therapeutics, at Asklepios BioPharmaceutical (AskBio — https://www.askbio.com/), where she is also member of the AskBio Board of Directors, and has responsibility for driving the strategic direction and execution of pre-clinical and clinical programs of the company.

AskBio is a wholly owned and independently operated subsidiary of Bayer AG, set up as a fully integrated gene therapy company dedicated to developing life-saving medicines that cure genetic diseases.

Continue reading “Dr. Katherine High, MD — Gene Therapy Pioneer — President, Therapeutics, Asklepios BioPharmaceutical” | >